Atika Capital Management »

Maze Therapeatics shares owned by Atika Capital Management

Quarter-by-quarter ownership of Maze Therapeatics (MAZE) shares owned by Atika Capital Management from 13F filings

Historical chart of Atika Capital Management investment in Maze Therapeatics

Tip: Access up to 7 years of quarterly data

All positions including Maze Therapeatics held by Atika Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maze Therapeatics by Atika Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.3M 112k 29.85

More positions owned by Atika Capital Management

Vaneck Etf Trust Gold Miners Etf Call Option (GDX)
Vertiv Holdings Com Cl A (VRT)
Spdr Series Trust State Street Spd Put Option (XBI)
Eli Lilly & Co. (LLY)
Vaneck Etf Trust Semiconductr Etf Put Option (SMH)
Intuitive Surgical Com New (ISRG)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Echostar Corp Cl A (SATS)
Seagate Technology Hldngs Pl Ord Shs (STX)
MasTec (MTZ)
Netflix (NFLX)
Ciena Corp Com New (CIEN)
Bwx Technologies (BWXT)
Terns Pharmaceuticals (TERN)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)

View all positions for Atika Capital Management

Top funds holding Maze Therapeatics

Frazier Life Sciences Management
Trv Gp Iv
Arch Venture Corp
Deep Track Capital
Henderson Group
Paradigm Biocapital Advisors
BlackRock
AH Capital Management
Vanguard Group
VR Adviser
Vanguard Capital Management
Alphabet
Logos Global Management
General Catalyst Group Management
TRV GP V

View all funds holding Maze Therapeatics